These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 6380596)

  • 1. Daunorubicin and doxorubicin, anthracycline antibiotics, a physicochemical and biological review.
    Aubel-Sadron G; Londos-Gagliardi D
    Biochimie; 1984 May; 66(5):333-52. PubMed ID: 6380596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Suppression of DNA synthesis in mice by the anthracycline antibiotics daunorubicin, carminomycin and doxorubicin].
    Reznikova MI; Dudnik IuV
    Antibiot Khimioter; 1988 Apr; 33(4):286-9. PubMed ID: 3389958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural requirements for anthracycline-induced cardiotoxicity and antitumor effects.
    Singh Y; Ulrich L; Katz D; Bowen P; Krishna G
    Toxicol Appl Pharmacol; 1989 Aug; 100(1):9-23. PubMed ID: 2763305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of the structure of new anthracycline antibiotics on their biological properties.
    Wasowska M; Oszczapowicz I; Wietrzyk J; Opolski A; Madej J; Dzimira S; Oszczapowicz J
    Anticancer Res; 2005; 25(3B):2043-8. PubMed ID: 16158943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Markedly reduced levels of anthracycline-induced DNA strand breaks in resistant P388 leukemia cells and isolated nuclei.
    Capranico G; Riva A; Tinelli S; Dasdia T; Zunino F
    Cancer Res; 1987 Jul; 47(14):3752-6. PubMed ID: 3474061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA topoisomerase II-mediated interaction of doxorubicin and daunorubicin congeners with DNA.
    Bodley A; Liu LF; Israel M; Seshadri R; Koseki Y; Giuliani FC; Kirschenbaum S; Silber R; Potmesil M
    Cancer Res; 1989 Nov; 49(21):5969-78. PubMed ID: 2551497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of the model of rat isolated perfused heart for the evaluation of anthracycline cardiotoxicity and its circumvention.
    Pouna P; Bonoron-Adèle S; Gouverneur G; Tariosse L; Besse P; Robert J
    Br J Pharmacol; 1996 Apr; 117(7):1593-9. PubMed ID: 8730759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin.
    Gewirtz DA
    Biochem Pharmacol; 1999 Apr; 57(7):727-41. PubMed ID: 10075079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA complexing antibiotics: daunomycin, adriamycin and their derivatives.
    Marco A; Arcamone F
    Arzneimittelforschung; 1975 Mar; 25(3):368-74. PubMed ID: 1174034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New anthracycline glycosides obtained by the nitrous acid deamination of daunorubicin, doxorubicin and their configurational analogues.
    Cassinelli G; Ballabio M; Arcamone F; Casazza AM; Podesta' A
    J Antibiot (Tokyo); 1985 Jul; 38(7):856-67. PubMed ID: 3861603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, biological and biochemical properties of new anthracyclines modified in the aminosugar moiety.
    Bargiotti A; Casazza AM; Cassinelli G; Di Marco A; Penco S; Pratesi G; Supino R; Zaccara A; Zunino F; Arcamone F
    Cancer Chemother Pharmacol; 1983; 10(2):84-9. PubMed ID: 6831630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mechanism for anthracycline-induced inhibition of collagen biosynthesis.
    Muszyńska A; Wolczyński S; Pałka J
    Eur J Pharmacol; 2001 Jan; 411(1-2):17-25. PubMed ID: 11137854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular pharmocodynamics of several anthrocycline antibiotics.
    Bachur NR; Steele M; Meriwether WD; Hildebrand RC
    J Med Chem; 1976 May; 19(5):651-4. PubMed ID: 1271407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of lipophilicity on cytotoxicity of anthracyclines in LoVo and LoVo/Dx human cell lines.
    Facchetti I; Grandi M; Cucchi P; Geroni C; Penco S; Vigevani A
    Anticancer Drug Des; 1991 Nov; 6(5):385-97. PubMed ID: 1764162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of human anthracycline reductases by emodin - A possible remedy for anthracycline resistance.
    Hintzpeter J; Seliger JM; Hofman J; Martin HJ; Wsol V; Maser E
    Toxicol Appl Pharmacol; 2016 Feb; 293():21-9. PubMed ID: 26773812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of membrane-associated calcium-independent phospholipase A2 as a potential culprit of anthracycline cardiotoxicity.
    Swift L; McHowat J; Sarvazyan N
    Cancer Res; 2003 Sep; 63(18):5992-8. PubMed ID: 14522926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequence-selective topoisomerase II inhibition by anthracycline derivatives in SV40 DNA: relationship with DNA binding affinity and cytotoxicity.
    Capranico G; Zunino F; Kohn KW; Pommier Y
    Biochemistry; 1990 Jan; 29(2):562-9. PubMed ID: 2154250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of three new anthracyclines and doxorubicin on the rat isolated heart.
    Chen ZM; Colombo T; Conforti L; Grazia Donelli M; Fiedorowicz RJ; Marchi S; Paolini A; Riva E; Zuanetti G; Latini R
    J Pharm Pharmacol; 1987 Nov; 39(11):947-50. PubMed ID: 2892924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacokinetics and action mechanism of anthracyclines].
    Fukushima T; Ueda T; Nakamura T
    Gan To Kagaku Ryoho; 1992 Apr; 19(4):445-50. PubMed ID: 1558393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-strand DNA breaks induced by chromophore-modified anthracyclines in P388 leukemia cells.
    Capranico G; Soranzo C; Zunino F
    Cancer Res; 1986 Nov; 46(11):5499-503. PubMed ID: 3463414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.